While these side effects are generally manageable and not directly related to varicose veins, they could still impact overall circulatory health
Current evidence, including the retrospective research by Stevens et al., suggests that Semaglutide use was not associated with increased risk of DR progression, visual loss, or increased intravitreal injections over a 3-year period 48
A long term commitment is not required
Key Results (Week 26 interim data): Semaglutide alone: 35% of weight lost was lean mass (which includes muscle) Combo w/ trevogrumab (anti-myostatin): Preserved ~50% lean mass loss
Women with PCOS who lose 510% of body weight often experience restoration of ovulation and improved menstrual cycles
Transwell migration assay Transwell filters (Costar, Corning, Cambridge, MA, USA) with 8.0 m pores were used for the migration assay